|
December 2006
Pain is big business
An aging world population with chronic pain spent $26 billion in 2006. That amount will increase to $33 billion by 2010, according to market research from Kalorama Information.
The 6 percent increase is based on strong performance in the neuropathic, musculoskeletal, and device pain treatment segments. However, the largest segment in 2006 will be cancer pain treatments with nearly $7 billion in revenues. The escalating world cancer incidence as well as the global focus on breakthrough cancer treatments will continue to keep this segment healthy over the next four years.
“The World Market for Pain Management Drugs and Devices” study examines the global market for therapeutics in the following categories: burn, cancer, dental/facial, migraine headache, musculoskeletal, neuropathic, obstetrical, pediatric, surgical, and trauma pain.
Source: Kalorama Information, www.kaloramainformation.com
|